Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


US trials of Cardima's ablation catheter begin:

This article was originally published in Clinica

Executive Summary

The first US patient has been successfully treated for atrial fibrillation with Cardima's Pathfinder ablation catheter. The 38-year old man, who had been suffering AF episodes almost every day over five years, was treated with the catheter and left hospital with a normal heart rhythm. The treatment was part of a feasibility trial of the device - a PMA trial is set to begin before the year end. In Europe, 12 patients have been treated so far for AF.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts